Skip to content

Clinical trials

Completed Obesity trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Status: Completed Country / region: New Zealand Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20112
20121
20131
20141
20152
20171
20211
20222
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim5
University of Auckland, New Zealand3
University of Otago2
Anne Birgitte Raben1
Australian and New Zealand Intensive Care Research Centre1
Carmot Therapeutics, Inc.1
Eisai Inc.1
Eli Lilly and Company1
North Shore Hospital, New Zealand1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity18
Diabetes Mellitus, Type 26
Overweight4
Body Weight1
Cardiovascular Diseases1
Critical Illness1
Diabetes Mellitus1
Glucose Intolerance1
Liver Diseases1
Nutrition Disorders1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.